Gene: GSTM4
Official Full Name: glutathione S-transferase mu 4provided by HGNC
Gene Summary: Cytosolic and membrane-bound forms of glutathione S-transferase are encoded by two distinct supergene families. At present, eight distinct classes of the soluble cytoplasmic mammalian glutathione S-transferases have been identified: alpha, kappa, mu, omega, pi, sigma, theta and zeta. This gene encodes a glutathione S-transferase that belongs to the mu class. The mu class of enzymes functions in the detoxification of electrophilic compounds, including carcinogens, therapeutic drugs, environmental toxins and products of oxidative stress, by conjugation with glutathione. The genes encoding the mu class of enzymes are organized in a gene cluster on chromosome 1p13.3 and are known to be highly polymorphic. These genetic variations can change an individual's susceptibility to carcinogens and toxins as well as affect the toxicity and efficacy of certain drugs. Diversification of these genes has occurred in regions encoding substrate-binding domains, as well as in tissue expression patterns, to accommodate an increasing number of foreign compounds. Multiple transcript variants, each encoding a distinct protein isoform, have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO37482 | GSTM4 Knockout cell line (HeLa) | Human | GSTM4 | 1:3~1:6 | Negative | Online Inquiry |
KO37483 | GSTM4 Knockout cell line (HCT 116) | Human | GSTM4 | 1:2~1:4 | Negative | Online Inquiry |
KO37484 | GSTM4 Knockout cell line (A549) | Human | GSTM4 | 1:3~1:4 | Negative | Online Inquiry |
GSTM4 Gene Knockout Cell Lines are genetically engineered cell lines that have had the GSTM4 gene specifically knocked out, leading to the loss of expression of the Glutathione S-Transferase M4 enzyme. This product allows researchers to study gene function, drug metabolism, and cellular responses without the confounding effects of GSTM4 activity. The knockout mechanism is facilitated by CRISPR-Cas9 technology or other targeted genetic techniques, providing a robust tool for elucidating the roles of the GSTM4 protein in various biological contexts.
The primary function of these cell lines is to enable detailed investigation of the physiological and pathological roles played by GSTM4 in drug metabolism and detoxification processes. By eliminating the GSTM4 gene, researchers can assess its impact on cellular responses to oxidative stress, electrophilic compounds, and anticancer therapies. Studies utilizing GSTM4 knockout models can reveal insights into mechanisms of drug resistance and identify potential therapeutic targets for enhanced treatment efficacy.
The scientific importance of GSTM4 Gene Knockout Cell Lines spans both clinical and research applications. In research settings, these cell lines are invaluable for pharmacological studies, providing a platform for drug screening and the investigation of metabolic pathways. Clinically, understanding the role of GSTM4 can inform the development of personalized medicine approaches tailored to individual genetic backgrounds, particularly for drugs that undergo extensive metabolic modification.
Compared to conventional cell lines that do express GSTM4, the GSTM4 Gene Knockout Cell Lines offer unique advantages, including the ability to reduce variability in experimental outcomes. This leads to more consistent and reproducible data, which is critical for validating research findings and translating them into clinical applications. Their specificity in eliminating GSTM4 activity allows for focused investigations into specific biochemical pathways without interference.
For researchers and clinicians grappling with the complexities of drug metabolism and pharmacogenomics, GSTM4 Gene Knockout Cell Lines represent a vital resource. By utilizing these advanced models, users can gain a deeper understanding of genetic influences on drug efficacy and toxicity, ultimately contributing to advancements in therapeutic interventions and personalized medicine.
Our company leverages state-of-the-art genetic engineering techniques and extensive experience in producing high-quality biological products, ensuring that our GSTM4 Gene Knockout Cell Lines meet the rigorous demands of modern research and clinical applications.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.